Can prescription drugs be advertised to consumers in Canada, and what does that mean for placements?
Part of US and Canada targeting
The short answer
Section C.01.044 of Canada's Food and Drug Regulations limits any prescription drug advertising to the general public to the brand name, proper name, common name, price and quantity. So consumer ads either name the drug without saying what it treats, a reminder ad, or discuss a condition without naming any drug.
Key takeaways
- C.01.044 limits consumer advertising of a prescription drug to its brand name, proper name, common name, price and quantity.
- Health Canada has treated a campaign whose branded and unbranded messages could easily be linked as a violation, even when each ad alone complied.
- Ad Standards says foreign media not directed to a Canadian audience, such as US television stations, are not subject to Canadian requirements.
- Health Canada's 2023 guidance says a message may be promotional if it is disseminated in the context of the target medical condition, which makes placement part of compliance.
Can prescription drugs be advertised to consumers in Canada?
Yes, but almost nothing about the drug can be said. Section C.01.044 of the Food and Drug Regulations (opens in a new tab) reads: if a person advertises a prescription drug to the general public, the person shall not make any representation other than with respect to the brand name, the proper name, the common name and the price and quantity of the drug. The regulations were current to September 30, 2026 when checked.
Definition
- Advertisement
- Under section 2 of the Food and Drugs Act (opens in a new tab), any representation by any means whatever for the purpose of promoting directly or indirectly the sale or disposal of any food, drug, cosmetic or device.
Two rules in the Act sit around C.01.044. Section 3(1) bars advertising any food, drug, cosmetic or device to the general public as a treatment, preventative or cure for the conditions in Schedule A.1, a list that includes asthma, cancer, depression, diabetes, hypertension, obesity and thyroid disease. Section 9(1) bars advertising a drug in a manner that is false, misleading or deceptive. Ad Standards' checklist adds that advertising controlled drugs and narcotics to the general public is prohibited.
| Rule | What it says | Source |
|---|---|---|
| C.01.044 | Consumer ads limited to brand name, proper name, common name, price and quantity | Food and Drug Regulations |
| Section 3(1) | No advertising to the general public as a treatment, preventative or cure for Schedule A.1 conditions | Food and Drugs Act |
| Section 9(1) | No advertising a drug in a false, misleading or deceptive manner | Food and Drugs Act |
| Market authorization | Promotion of a drug before it is authorized for sale is not permitted | Ad Standards DTCA checklist, citing s. 9(1) and C.08.002 |
| Controlled drugs | Advertising controlled drugs and narcotics to the general public is prohibited | Ad Standards DTCA checklist, citing G.06.004 |
What are reminder ads and help seeking ads?
The two terms describe the two shapes a Canadian consumer message can take. A reminder ad names the drug and stays inside C.01.044, so it never says what the drug is for. A help seeking ad, which Ad Standards reviews under its Direct-to-Consumer Information (DTCI) framework for disease related information messages, talks about a condition and invites people to see a health professional, without naming any drug.
| Message type | What it contains | Status in Canada |
|---|---|---|
| Reminder ad | Brand, proper or common name, price, quantity; no indication or benefit | Permitted within C.01.044 |
| Help seeking or disease information message | Information about a condition; no drug named | Reviewed under Ad Standards' DTCI framework as non-advertising information |
| Product claim ad | Drug name together with what it treats and its benefits | Not permitted to the general public under C.01.044 |
Ad Standards' 2026 DTCA checklist (opens in a new tab) shows how strict the reminder form is. It rejects an ad that directly or indirectly communicates the indication or a product characteristic such as a dosing schedule, judging audio, visuals, hashtags, keywords and hyperlinks as well as the copy. A link, URL or QR code to the corporate website must be removed, and a reference to a medical specialist such as a dermatologist is rejected.
Who reviews health product advertising in Canada?
Health Canada's guidance on the distinction between advertising and other activities (opens in a new tab), published July 31, 2023, states that Health Canada is the regulatory authority for all health product advertising in Canada. Independent agencies handle review and advisory work, and Health Canada's advertising requirements page (opens in a new tab) sets out who does what.
| Body | Role described by Health Canada |
|---|---|
| Health Canada | Regulatory authority; may intervene when a prescription drug is illegally advertised to the general public |
| Pharmaceutical Advertising Advisory Board (PAAB) | Reviews and preclears advertising for health products directed to health professionals; gives advisory opinions on consumer prescription drug messages and disease education material |
| Ad Standards | Gives advisory opinions on consumer prescription drug messages and disease education material |
| Other preclearance agencies | Review nonprescription drug and natural health product advertising directed to consumers |
The checklist marks a boundary for planners. Ad Standards does not review messages directed to health care professionals under the consumer framework, but it treats material visible to the public in physician waiting rooms as consumer facing. The same logic applies online: a page any member of the public can open is a consumer setting, whoever the ad was written for.
What happens when US pharma ads reach Canadians?
The two countries start from opposite rules. In the US, consumer ads that name a drug and what it treats are regulated under 21 CFR 202.1 rather than banned, as the US rules page explains. The FDA's prescription drug promotion FAQ (opens in a new tab) defines reminder advertisements as ads that call attention to the name of the drug product but do not include indications or dosage recommendations.
Spillover is addressed in Ad Standards' checklist. Advertisements appearing in foreign media that are not directed to or intended for a Canadian audience are not subject to Canadian regulatory requirements. The checklist defines foreign media as media originating outside Canada, such as commercials on US television stations and ads in foreign magazines sold in Canada. A digital campaign that targets Canadian locations is a different case, because it is directed at a Canadian audience by design.
Platform eligibility follows the same map. Google's pharmaceutical manufacturers policy (opens in a new tab) lists Canada, New Zealand and the United States as the locations where certified manufacturers may promote prescription drugs. Eligibility on the platform does not change what C.01.044 allows the ad to say in Canada.
Four steps to sort a cross-border drug placement list
- Split the list by audience country. Mark each site as mainly US, mainly Canadian or shared, using country popularity data rather than domain endings.
- Assign one message type per list. US placements can carry the US campaign; Canadian placements carry only a reminder ad or an unbranded information message.
- Set location targeting to match. Keep US product claim creative out of Canadian locations in the buying platform.
- Recheck shared sites. A US site with a large Canadian readership gets the Canadian treatment when the ad targets Canada.
What does this mean for health content placements?
Placement can decide whether a reminder ad stays a reminder ad. Health Canada's 2023 guidance says a message may be promotional if it is disseminated in the context of the target medical condition when directed to the general public, or if it is combined or disseminated at the same time as other promotional messages. Ad Standards adds that a branded ad and a disease information message disseminated together or in proximity can let consumers connect the drug with its indication, in violation of C.01.044.
Placement checks for a Canadian prescription drug flight
- Reminder ads are not placed on pages, channels or search terms about the condition the drug treats.
- Keywords, hashtags and links used for targeting do not name or imply the indication.
- Branded and unbranded messages run on separate lists, at separate times, with no shared style, music, people or wording.
- Health condition content on the plan carries only the unbranded information message.
- Location targeting separates Canadian placements from US flights that carry product claim ads.
- The plan records whether each Canadian message has a PAAB or Ad Standards advisory opinion.
Fictional example
A Detroit drugmaker's eczema campaign meets the border
A fictional Michigan maker of a prescription eczema cream runs a US product claim campaign on skin care and parenting sites across the Detroit area. Its agency notices that several of those sites are popular in Windsor and southwestern Ontario, and that the client also wants a Canadian presence.
The agency splits the plan. US product claim ads are limited to US locations. For Canada it prepares a reminder ad with the brand name only, placed on general news and lifestyle sites, and a separate unbranded message about eczema care with its own look and voice, placed on skin health content at a different time. Both go for an advisory opinion before launch.
How does PlacementGraph help separate a Canadian health plan from a US one?
Splitting a cross-border health plan starts with knowing which sites Canadians actually read, which is what PlacementGraph's market fit measures.
Frequently asked questions
Can vaccines be advertised to consumers in Canada?
Some can. Ad Standards' checklist says drugs such as vaccines and insulin that are in Schedule D but not on the Prescription Drug List are not subject to C.01.044 and may be advertised to consumers. Health Canada has issued interim guidance on fair balance in consumer vaccine advertising. Where a product is on both lists, the stricter prescription rules apply.
Can a Canadian reminder ad mention more than one drug?
Ad Standards rejects an ad that includes the brand or chemical name of multiple drug products. It accepts a list of participating products in a patient assistance or savings program message, if no drug is promoted over the others, and a general price callout such as available at the same price as generics.
Do health professional ads follow the same rules as consumer ads?
Health Canada describes the Pharmaceutical Advertising Advisory Board as reviewing and preclearing health product advertising directed to health professionals, a separate track from consumer messages. Ad Standards notes that material visible to the public, such as in physician waiting rooms, is treated as consumer facing and reviewed under the consumer framework.
Does the drug have to be authorized before any advertising runs?
Ad Standards' checklist says promotion of a drug before market authorization is not permitted, citing section 9(1) of the Food and Drugs Act and section C.08.002(1) of the regulations, and it will not review a message for a drug Health Canada has not authorized for sale in Canada.
Sources
- Food and Drug Regulations (C.R.C., c. 870), full text (opens in a new tab)Justice Laws Website, Government of Canada
- Food and Drugs Act (R.S.C., 1985, c. F-27), full text (opens in a new tab)Justice Laws Website, Government of Canada
- Prescription Drug Advertising (DTCA) Checklist (opens in a new tab)Ad Standards, 2026
- Advertising Campaigns of Branded and Unbranded Messages (opens in a new tab)Health Canada, November 2000, updated August 2005 (hosted by Ad Standards)
- Guidance on distinction between advertising and other activities for health products (opens in a new tab)Health Canada, July 31, 2023
- Regulatory requirements for advertising (opens in a new tab)Health Canada
- OPDP Frequently Asked Questions (opens in a new tab)US Food and Drug Administration
- Pharmaceutical manufacturers (opens in a new tab)Google Advertising Policies Help
Researched and written by PlacementGraph Research. Read how we research, source and update these pages. Corrections: diana@placementgraph.com.